PD-L1 expression in tumour microenvironment supports the rationale for immune checkpoint blockade in classic Kaposi's sarcoma

被引：10
|
作者：
Genovese, G. [1 ,2 ]
Venegoni, L. [2 ]
Fanoni, D. [2 ]
Tourlaki, A. [1 ]
Brambilla, L. [1 ]
Berti, E. [1 ,2 ]
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UOC Dermatol, Milan, Italy
[2] Univ Milan, Dipartimento Fisiopatol Medicochirurg & Trapianti, Milan, Italy
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2019年 / 33卷 / 07期
关键词：
D O I：
10.1111/jdv.15543
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E269 / E271
页数：3
相关论文
共 50 条
  • [1] The Upregulation of Immune Checkpoint Ligand PD-L1 in Tumour Microenvironment
    Xu, W.
    Jiang, H.
    Gao, J.
    Zhao, Y.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2014, 80 (01) : 71 - 72
  • [2] The stage-dependent PD-L1 Expression in the Tumor Microenvironment of Kaposi's Sarcoma shields the Tumor against the Immune System
    Joest, B.
    Kempf, W.
    Berisha, A.
    Peyk, P.
    Tronnier, M.
    Mitteldorf, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 47 - 48
  • [3] PD-L1 expression and tumour microenvironment immune type groups in meningioma
    Turner, C.
    Mclay, J.
    Correia, J.
    Highet, B.
    Curtis, M.
    Hermans, I.
    Dragunow, M.
    HISTOPATHOLOGY, 2022, 81 : 142 - 142
  • [4] PD-L1 and Emerging Biomarkers in Immune Checkpoint Blockade Therapy
    Cottrell, Tricia R.
    Taube, Janis M.
    CANCER JOURNAL, 2018, 24 (01): : 41 - 46
  • [5] Anaplastic Classic Kaposi Sarcoma: PD-L1 Expression and Response to Immunotherapy: A Case Report and Review of the Literature
    Lolli, Ivan
    Valentini, Anna Maria
    Ricci, Angela Dalia
    Armentano, Raffaele
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (05): : 442 - +
  • [6] PD-L1 Expression in Sebaceous Carcinoma of the Eyelid Implicates the Utility of Immune Checkpoint Blockade
    Van Arnam, John
    Curry, Jonathan L.
    Nagarajan, Priyadharsini
    Aung, Phyu P.
    Lazar, Alexander J.
    Prieto, Victor G.
    Esmaeli, Bita
    Tetzlaff, Michael T.
    MODERN PATHOLOGY, 2017, 30 : 438A - 438A
  • [7] PD-L1 Expression in Sebaceous Carcinoma of the Eyelid Implicates the Utility of Immune Checkpoint Blockade
    Van Arnam, John
    Curry, Jonathan L.
    Nagarajan, Priyadharsini
    Aung, Phyu P.
    Lazar, Alexander J.
    Prieto, Victor G.
    Esmaeli, Bita
    Tetzlaff, Michael T.
    LABORATORY INVESTIGATION, 2017, 97 : 438A - 438A
  • [8] Phytochemicals in regulating PD-1/PD-L1 and immune checkpoint blockade therapy
    Zhang, Qi
    Yang, Chenying
    Gao, Xingsu
    Dong, Ju
    Zhong, Caiyun
    PHYTOTHERAPY RESEARCH, 2024, 38 (02) : 776 - 796
  • [9] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2016, 11 (06) : 385 - 390
  • [10] Predictive biomarkers for PD-1 and PD-L1 immune checkpoint blockade therapy
    Song, Yue
    Li, Zhaoming
    Xue, Weili
    Zhang, Mingzhi
    IMMUNOTHERAPY, 2019, 11 (06) : 515 - 529
12345